SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : BJCT-BIOJECT-needle less injection product
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Michael C. Woodward who wrote (64)11/5/1997 10:32:00 AM
From: Keith R.  Read Replies (2) of 534
 
A few thoughts re: Bioject:

*Besides the obvious benefit of Elan making a large investment in the company, there is one large side benefit. Prior to this deal, BJCT had been talking with no less than 5 major pharmaceutical Co.'s (i.e. N. Amer. Vaccines, JNJ, Teva and others). re: deals that would bundle the Biojector with various proprietary vaccines and drugs. The biggest impediment to these deals being consummated were: 1)the financial condition of BJCT and , 2) more importantly, the lack of a "pre-fill" technology as nobody wanted to be a trailblazer, helping BJCT to develop this technology. Now that both of these have been solved with the Elan deal, one or more of these large Co.'s could come on board in the fairly near term.

*Flu shot programs, include Walmart appear to be doing well.

*At least four new states or municipalities will be signed in the near term for immunization programs.

*BJCT will be making a presentation to Hambricht & Quist Preferred Technology as well as a group of large investors in Boston on Thursday and Friday 11/7-11/8. There should be some interest generated from this meeting. A friend/investment advisor of mine has an associate who will be attending this meeting.

Good luck,
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News